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few studies have focused on changes in both the clinical
picture and venous function in patients with primary (not
post-thrombotic) disease.7 Large prospective studies on
the development of post-thrombotic syndrome clearly
demonstrated that in 20% to 40% of all patients, neither
clinical nor functional changes progress.8-9 Some patients
have edema, lipodermatosclerosis, and ulcers; other
patients, despite the presence of valvular incompetence,
remain asymptomatic over a significant time interval.
This diversity in the dynamics of CVI creates addi-
tional questions when the results of the treatments are
studied. Because the mean follow-up of the observational
period is limited, a disproportionate number of patients
with different types of clinical dynamics in the sample may
influence the results. However, the results of surgical
treatment have not previously been investigated in terms
of possible differences in the clinical progression of CVI.
The aim of this project was to study the effect of deep
vein valve reconstruction on the progression of CVI. To
investigate this issue, we determined the type of clinical
dynamics in every patient before surgery; in other words,
we estimated the time necessary to observe changes in
clinical status. We then monitored the function of the cor-
rected valve after surgery to distinguish cases in which the
Surgical correction of valvular incompetence has been
shown to be effective in the treatment of advanced stages
of venous disease.1-4 When correction of deep venous
reflux was not performed, superficial venous stripping and
perforator vein interruption were not as successful as when
deep reflux was not present.5 If improvement of abnormal
venous hemodynamics can be achieved by surgical recon-
struction of a single valve in the deep venous system,6,15
then this procedure may be done in earlier stages to pre-
vent the disease from progressing. We know of no reports
on the performance of valvuloplasty in the early stages of
chronic venous insufficiency (CVI).
The commonly accepted hypothesis is that physiologic
changes and clinical signs of CVI are not static but rather
progress from simple varicose veins to skin ulceration. This
acceptance is based mainly on clinical observations. Only a
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Purpose: We tested the hypothesis that the course of primary chronic venous insufficiency can be changed by correction
of the incompetent valve in the superficial femoral vein.
Methods: This was a prospective, randomized, controlled study. A total of 125 extremities with reflux in greater saphe-
nous and superficial femoral veins and belonging to clinical classes C2-C4 were analyzed. During the first 5 years, the
type of clinical dynamics and changes in valvular function were determined in each patient. Patients were stratified
according to the type of clinical dynamics and randomly assigned to treatment groups. Phlebectomy was performed in
all extremities. In each of 64 extremities (the study group), the proximal incompetent superficial femoral vein valve was
corrected as a part of the primary intervention. Patients were followed up for 7 to 8 years after surgery.
Results: The clinical dynamics of the extremity significantly depended on reflux changes. Increase in superficial femoral
vein reflux was found in 74% of the extremities with progressive clinical dynamics but in only 47% of extremities with
stable clinical dynamics (χ2 = 9.71; P < .01). After surgical treatment, 65% of the extremities in the control group
showed stable improvement; in 11%, recurrent varicosity was found; in 24%, the disease was aggravated. Of the extrem-
ities in the study group, 86% had stable improvement, 5% had recurrent varicosity, and 10% were aggravated (P < .05).
Extremities with the progressive type of clinical dynamics were main contributors to this difference (χ2 = 7.86; P < .05).
In 92% of the extremities with corrected valves and in 50% of the extremities with increase in reflux after valvuloplasty,
clinical improvement was observed (χ2 = 11.5; P < .01). Extremities with corrected valvular function demonstrated
superior results in comparison with extremities with stable valvular function in the control group (clinical improvement
in 92% and 66% of extremities, respectively; P < .005).
Conclusions: In patients with chronic venous insufficiency, two types of clinical dynamics, stable and progressive, can be
identified. The progressive type is associated with the presence of superficial femoral vein reflux and increasing greater
saphenous vein reflux. Superficial vein surgery neither corrects superficial femoral vein reflux nor prevents it from pro-
gressing further. Correction of a single superficial femoral vein valve during primary intervention significantly improves
the long-term results of superficial venous surgery. This improvement is associated with the prevention of reflux pro-
gression. Surgical correction of the incompetent superficial femoral vein valve changes the course of primary chronic
venous insufficiency. (J Vasc Surg 2001;33:361-8.)
correction remained effective from cases of recurrent valve
insufficiency. Finally, we observed the clinical dynamics
after surgery over time intervals longer than those needed
for clinical changes.
MATERIAL AND METHODS
The research was designed as a prospective, random-
ized, controlled study. Patients undergoing valvuloplasty
formed the study group. Patients in whom only phlebec-
tomy was performed formed the control group.
Study design. Primary CVI was diagnosed in a total
of 1879 patients during the period 1983-1984. Post-
thrombotic disease was ruled out by careful examination
of medical history, results of ultrasound scan examination,
and, when necessary, phlebography. Specifically, any
patient with a history of deep venous thrombosis, episodes
of acute edema of the lower extremity, trauma, major
surgery, or a hospital stay with bed rest longer than 3 days
was excluded from the study. Patients with ultrasound
scan findings of segmental thickening of the venous wall
(four patients) or partial or complete occlusions of the
vein (eight patients) were also excluded. In 27 patients
with questionable ultrasound scan findings, antegrade
phlebography was performed; 8 patients with occlusions
of the veins, 2 patients with stenosis of the veins, and 5
patients with massive collateral venous pathways were
diagnosed with post-thrombotic disease and excluded. Of
the patients with primary disease, 168 (169 extremities)
were selected for the study.
The selection criteria were (1) clinical class C2, C3, or
C4 (CEAP classification10) and (2) reflux demonstrated
by duplex ultrasound can in both the proximal greater
saphenous vein (GSV) and the superficial femoral vein
(SFV). Informed consent was obtained from each patient.
Reflux assessment included duplex ultrasound scanning
in all patients. In addition to SFV and GSV reflux, which
was present in all selected extremities, 12 extremities
demonstrated popliteal vein incompetence. The profunda
femoris vein was not examined for valvular function. Reflux
duration of more than 0.5 second was considered patho-
logic. The reflux volume index (RVI)11-13 was used for
evaluation of reflux severity and dynamics. Findings were
confirmed by retrograde phlebography in 86 patients.
Elastic compression was recommended for each
patient at the first visit. We observed all patients for 5 years
with annual clinical and ultrasound scan examinations. 
Changes in the clinical class of the extremity were
defined as being of a progressive type of clinical dynamics if the
extremity demonstrated an increase of at least one clinical
class by the end of the fifth year in comparison with the ini-
tial class of the limb. If no change in clinical class was
observed, the clinical dynamics was defined as the stable type.
At the end of the fifth year, 149 patients remained in
the study (19 patients had withdrawn from the study by
virtue of the fact that they refused to undergo surgery). A
total of 128 of these patients agreed to undergo surgical
treatment, and only these 128 patients were finally
included in the study (Table I).
Patients were stratified according to the type of clini-
cal dynamics and then randomly assigned to treatment
groups. Surgical treatment was performed in 128 extrem-
ities with reflux in the SFV (unilateral operations were per-
formed in all 128 patients).
Surgical procedures included phlebectomy (GSV strip-
ping with stub avulsion of varicose tributaries) in all
extremities. Phlebographically confirmed, incompetent,
perforating veins were subfascially ligated in 41 extremities
through use of the open long medial vertical approach. In
each of 64 extremities (the study group), the proximal
incompetent SFV valve was corrected with Kistner’s tech-
nique3; this was in addition to the superficial surgery.
Patients were followed up for 7 to 8 years after surgery.
Three patients (two from the control group and one from
the study group) were lost to follow-up; data on those
three patients were not included in the final statistical
analysis (125 extremities were analyzed). Duplex ultra-
sound scanning and clinical examination were performed 1
month after surgery and annually thereafter. Distribution
of the patients between the two groups is presented in
Tables II and III. 
Clinical results of the surgical treatment were desig-
nated stable improvement if no increase in clinical class was
identified during follow-up. For any extremity whose class
before surgery was C6, a result of class C5 was considered
an improvement. An increase in clinical class was desig-
nated aggravation. Cases of recurrent varicosity were ana-
lyzed separately, but this was considered aggravation.
Ultrasound scan examination. The technique of
ultrasound scan examination was similar to that described
by van Bemmelen at al.14 All measurements were made
with the patient standing and supporting most of his or
her weight on the contralateral leg. A pneumatic calf with
deflator was applied 2 to 5 cm distally to the site of mea-
surement. The GSV, the proximal and midthigh segments
of the SFV, the popliteal vein, and the lesser saphenous
vein (LSV) at 2 to 4 cm distal to the saphenopopliteal
junction were all examined. Rapid calf deflation was used
to initiate the reflux. All measurements were repeated 3
times at each site, and average values were used.
The reflux time (RT) and RVI were used to estimate
valve function. The RVI was defined as the percentage of
volume generated by cuff inflation that flowed back dur-
ing reflux. Antegrade and retrograde flow volumes are the
product of the vein diameter, flow velocity, and time of
augmentation or reflux. (These values might be calculated
by multiplying the vein diameter by time integral of flow
velocity for augmentation or reflux. However, because
measurements of the flow are performed in exactly the
same cross-section of the vessel, diameters were excluded
from the equation.)
RVI = (RV/AV) × 100% = (Dv × AR/Dv × AA) ×
100% = (AR/AA) × 100%,
where RV is the reflux volume, AV is the augmented ante-
grade volume during cuff inflation, Dv is the diameter of
the vein, and AR and AA are the time integrals of flow
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velocity (area under the Doppler spectral curve) during
reflux and augmentation, respectively.
Our previous study of 30 patients showed the RVI to
have a high reliability. The test-retest reliability coefficient
was 0.98 when the second test was performed within 1
hour of the first. When the second test was performed 7
days later, the test-retest reliability coefficient was 0.96.13
RESULTS
During the first 4-5 years of observation, 82 extremi-
ties demonstrated the progressive type of clinical dynam-
ics. The remaining 43 extremities showed no changes in
CVI clinical class (Table IV).
After the surgical treatment, 40 extremities of the con-
trol group (superficial surgery) demonstrated stable
improvement. Recurrent varicosities were found in seven
extremities. The disease was aggravated in 15 extremities
(Table V). Of the 63 extremities in the study group
(valvuloplasty of the SFV), 54 demonstrated improvement
in clinical class, 3 had recurrent varicosities, and 6 demon-
strated an increase in clinical class. The overall difference
in the results between the two groups was significant (P <
.05). Extremities with the progressive type of clinical
dynamics were main contributors to this difference (χ2 =
7.86; P < .05). In the control and study groups, the results
in patients with the stable type of clinical dynamics were
not significantly different (χ2 = 1.02; P > .1).
The investigation of preoperative and postoperative
function of the proximal SFV valve was important because
this valve was corrected by valvuloplasty. During the first
ultrasound scan examination, each of 12 extremities had 
an RT of more than 2 seconds, each of 19 extremities had an
RT of 0.6 to 0.9 second, and each of 94 extremities had 
an RT of 1 to 2 seconds. The RVI exceeded 1.0 in 13
extremities; each of 9 extremities had an RVI of less than 0.4,
and each of 103 extremities had an RVI of 0.4-1.0.
During the first 5 years of observation, an increase in
SFV reflux was registered in 81 extremities. In the remaining
44 cases, reflux had not changed. Increased SFV reflux was
associated with increased GSV reflux in 66 extremities. In 15
extremities, GSV reflux remained stable while SFV reflux
progressed (Table VI). The clinical dynamics of the extrem-
ity significantly depended on reflux changes (P < .01).
An increase in SFV reflux was found in 74% of extrem-
ities with the progressive type of clinical dynamics but in
only 47% of extremities with the stable type of clinical
dynamics (χ2 = 9.71; P < .01).
Changes in SFV reflux after surgery were investigated
in 121 extremities. In the control group, reflux remained
the same in 29 extremities, but 33 extremities demon-
Table I. CEAP classification of 128 extremities included in this series
CEAP classification
CC Etiol Anatomy Path No. of extremities
2 P S(3), D(13) R 12*
C2 P S(2,3), D(13) R 25*
C2 P S(2,3), D(13), P(18) R 14
C3 P S(3), D(13) R 4*
C3 P S(2,3), D(13) R 36
C3 P S(2,3,4), D(13) R 1
C3 P S(2,3), D(13,14), P(18) R 4
C4 P S(2,3), D(13) R 7
C4 P S(2,3,4), D(13) R 2
C4 P S(2,3), D(13), P(18) R 15
C4 P S(2,3), D(13,14), P(18) R 8
CC, Clinical class; Etiol, etiology; Path, pathophysiology; P, primary; S, superficial (2, GSV above knee; 3, GSV below knee; 4, LSV); D, deep (13, SFV; 14,
popliteal vein); P, perforators (18, calf); R, reflux.
*One case was lost to follow-up after surgery.
Table II. Surgical operations performed in 125 extremities in this series
No. of extremities
Surgical operation Control group Study group
GSV stripping 62 63
Stub avulsions of tributaries 62 63
LSV stripping 1 2
Subfascial perforators ligation 21 20
SFV valvuloplasty 0 63
strated increase in reflux during follow-up. None of the
extremities in the control group demonstrated decrease in
reflux after surgery.
Immediately after valvuloplasty, the RT was less than
0.5 second in every extremity. This suggests that compe-
tence had been achieved at surgery in all limbs.
We used two different approaches to describe the func-
tion of the repaired valve. The first of these was a qualita-
tive description of the presence of reflux (either corrected
reflux or reappearance of reflux). Reappearance of reflux
was defined as an RT of more than 0.5 second when regis-
tered during follow-up in an extremity that had had an RT
of less than 0.5 second immediately after surgery.
Use of the RVI allowed us to introduce a second,
quantitative description of reflux changes. Increase in
reflux after surgery was defined as increase in the RVI dur-
ing follow-up.
After valvuloplasty, the corrected valve remained com-
petent during follow-up in 45 extremities. Reappearance
of reflux was observed in 12 extremities, the time
sequence being as follows: for 2 extremities, 2 years post-
surgery; for 8 extremities, 3 years postsurgery; for 2
extremities, 4 years postsurgery (Fig 1). Increase in reflux
was observed in 10 extremities (Fig 2). In 8 extremities,
both reappearance and increase in reflux were registered.
We had methodologic difficulties with the interpreta-
tion of reflux dynamics in four extremities of the study
group. In two extremities, the RT did not exceed 0.5 sec-
ond during follow-up but an increase in the RVI was
observed. In these cases, the RTs were 0.2 and 0.3 second
and the RVIs 0.35 and 0.32 immediately after surgery.
During follow-up, the RT continued to be 0.2 second in
the first extremity and increased to 0.4 second in the second
extremity. These values are considered to be in the normal
range, but the RVI began to increase 2 years after surgery
in the first extremity and 3 years after surgery in the second
extremity, the values reaching 0.87 and 0.75, respectively,
by the end of follow-up. Another two extremities demon-
strated reappearance of reflux without changes in the RVI.
All four of these extremities had clinical improvement. 
Worsening of clinical status was observed in only 8% of
the extremities with corrected valves (RT < 0.5 second and
no RVI increase during follow-up). In contrast, 50% of the
extremities with increase in reflux demonstrated clinical
aggravation (χ2 = 11.5; P < .01). However, only 25% of
the extremities in which reflux reappeared but did not
increase (the RT became longer than 0.5 second but the
RVI remained the same during follow-up) demonstrated
an increase in clinical class (χ2 = 2.59; P > .05). Thus, clin-
ical aggravation is associated with increase in reflux over
time to a greater extent than with reappearance of reflux
after valvuloplasty.
DISCUSSION
Types of clinical dynamics. In this investigation, we
did not analyze the factors that influence the type of clin-
ical dynamics. Our previous study, however, showed no
significant differences between patients with the progres-
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Table III. Clinical dynamics and clinical class of 2 groups 
Clinical class at time of surgery (no. of extremities)
Group Clinical dynamics C2 C3 C4 C6 Total
Control
Stable 6 9 6 0 21
Progressive 0 4 24 13 41
Study
Stable 7 9 6 0 22
Progressive 0 4 23 14 41
Table IV. Maximum clinical class during first 5 years of observation
Clinical class
Initial assessment Assessment at 5 y No. of extremities
C2 C2 13
C2 C3 8
C2 C4 24
C2 C6 4
C3 C3 18
C3 C4 23
C3 C6 3
C4 C4 12
C4 C6 20
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sive type of clinical dynamics and patients with the stable
type in age, number of pregnancies, type and intensity of
physical activity, and presence of concomitant diseases.13
In this study, patients were observed for 5 years before
surgery and stratified according to the type of clinical
dynamics. This approach minimizes sample bias resulting
from the type of clinical progression or the time when
clinical changes might be registered. In patients with the
progressive type of clinical dynamics, changes in clinical
class occurred in less than 5 years, which was the follow-
up time interval (TI). Follow-up time after surgical inter-
vention was more than 8 years. The fact that the follow-up
time exceeded TI allows us to conclude that cases of clin-
ical improvement or even stable clinical status after surgery
are due to changes in the course of the disease. 
On the other hand, one cannot conclude that there is
no difference between the control and treatment groups
for the stable clinical type, because the exact TI is
unknown and may be greater than 5 years. The absence of
clinical changes in these patients may be due to the slow
development of signs and symptoms.
Reports on the results of valvuloplasty1-4,15 have not
accounted for the type of clinical dynamics. We found the
results to be different in patients with different types of
clinical dynamics. This can lead to overestimation of the
improvement rate if a large number of patients with stable
clinical dynamics is included in the group. In our study, for
example, the improvement rate in the control group was
90% for the stable type of clinical dynamics but only 51%
for the progressive type (P < .05).
Another possible danger of mixing the two types of
clinical dynamics is underestimation of the difference
between the groups. In our series, for example, patients
with the progressive type of clinical dynamics had a signif-
icantly higher rate of improvement in the study group
(81%) than in the control group (51%; P < .05). In con-
trast, extremities with the stable type of clinical dynamics
demonstrated almost the same rate of improvement in
both groups (96% in the study group, 90% in the control
group; P > .01). It is therefore important to analyze each
type of clinical dynamics separately or at least provide the
information on how many patients with each type of
dynamics were included in the study population.
Proximal SFV valve function. Failure to adequately
monitor valve function after surgery might lead to misin-
terpretation of clinical results. If the function of the cor-
rected valve is unknown or not reported,1-4,15 it is difficult
to distinguish those cases of clinical aggravation that are
due to recurrence of valve insufficiency from those that are
due to other factors that develop despite the absence of
SFV reflux.
In this study, an RT of more than 0.5 second was used
as the criterion for presence of reflux. During the first 5
years of observation, the RT did not change significantly
in 22 patients; in 21 patients, the RT increased. In eight
patients, the RT decreased but was never less than 0.8 sec-
ond. In 74 patients, the RT fluctuated from one examina-
tion to the next, demonstrating increase during 1 year and
decrease during another. Of the patients with constant
increase in RT, 48% had progressive clinical dynamics and
52% had stable clinical dynamics. Six patients with
decreased RT demonstrated progressive clinical dynamics.
RT did not correlate with clinical class, type of clinical
dynamics, or RVI.
It has been shown by others that RT does not corre-
late with physiologic parameters such as volume of reflux
Table V. Surgical treatment results in the extremities with stable or progressive clinical dynamics
Result of surgical treatment (%)
Group Type of clinical dynamics before surgery Stable improvement Aggravation Recurrence
Control Stable (n = 21) 90 5 5
Progressive (n = 41) 51 34 15
Study Stable (n = 22) 95 0 5
Progressive (n = 41) 80 15 5
Table VI. Reflux changes and clinical dynamics during first 5 years of observation
Clinical dynamics
Reflux changes Progressive Stable Total
SFV GSV Number of extremities
Increased Increased 56 10 66
Increased Same 5 10 15
Same Increased 14 4 18
Same Same 7 19 26
and venous pressure.16-17 Moreover, changes in RT were
found not to correlate with clinical changes.18 On the
basis of these reports and our own observations, we
believe that RT cannot be used for reflux quantification or
for measurement of changes in reflux.
We used the RVI for quantitative monitoring of reflux
changes. It has been reported that the RVI is reliable and
correlates with both clinical changes in the extremities and
results of surgical treatment.12-13,18-19
During observation before surgical intervention,
increase in reflux through the proximal SFV valve was asso-
ciated with the progressive type of clinical dynamics; 74% of
the extremities with the progressive type of clinical dynam-
ics, as opposed to 47% of the extremities with the stable
type, had an RVI increase during the first 5 years (P < .01).
Changes in GSV reflux have a stronger influence on
the clinical dynamics of the extremities than do changes in
SFV reflux. Although 85% of extremities with increased
reflux in both the SFV and the GSV demonstrated the
progressive type of clinical dynamics, only 33% of the
extremities with increased SFV reflux but unchanged GSV
reflux had a clinical class increase during the first 5 years.
In contrast, 78% of the extremities with no change in SFV
reflux but an increase in GSV reflux demonstrated the pro-
gressive type of clinical dynamics (Table VI). We empha-
size that these observations are related to changes in reflux
(ie, changes in the RVI), not to the presence of reflux.
Thus, the fact that in the absence of reflux changes in both
the SFV and the GSV, 27% of extremities clinically pro-
gressed at least to the next class might be interpreted as
indicating that the presence of reflux itself can contribute
to clinical deterioration. From these observations, we are
not able to predict clinical changes after surgical treat-
ment. However, we believe that the observation of an 85%
incidence of clinical aggravation in extremities with
increases in both SFV and GSV reflux, in contrast with a
27% incidence of aggravation in extremities with stable
reflux, supports the necessity of correction for both veins. 
We were unable to confirm observations that superfi-
cial venous surgery abolishes the deep venous reflux.20-21
This form of surgical treatment did not significantly
change SFV function in the control group. In eight
extremities, there was a slight decrease in the RVI imme-
diately after surgery; none of these extremities, however,
had an RT of less than 1 second. During follow-up, the
RVI increased in all eight of these extremities, exceeding
its preoperative value. We therefore conclude that superfi-
cial venous surgery does not have significant impact on
deep venous reflux.
The pattern of changes in reflux observed before sur-
gical treatment persisted after surgery in all but three
extremities of the control group. Increase in SFV reflux
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Fig 1. In 12 extremities of study group, RT changes with reappearance of reflux during follow-up.
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after phlebectomy was observed in 33 extremities. Before
surgery, 31 of these 33 extremities had progression of
reflux and two had stable reflux. These two observations
suggest that in some cases changes in reflux might occur
after 5 years. 
The reappearance of reflux after valvuloplasty has been
reported in the literature.6,15 In our series, a significant pro-
portion of the study group (19%) demonstrated reappear-
ance of and/or increase in reflux. The time of reappearance
was more than 1 year after operation. Most instances of reap-
pearance of reflux occurred during the third year of follow-
up. SFV reflux changes after valvuloplasty, unlike those in the
control group, did not correlate with reflux pattern before
surgery. Increase in SFV reflux after valvuloplasty was regis-
tered with the same frequency in extremities that demon-
strated stable reflux before surgery (16%) as in extremities
with stable reflux before surgery.
Proximal SFV valve function and results of the
valvuloplasty. Sequential surveillance of valvular function
allowed us to separate cases with corrected valves from
cases in which reflux reappeared or increased. As expected,
clinical results were better in extremities with corrected
valves. We observed clinical improvement in 92% of the
extremities in which the valves remained corrected and in
only 50% of the extremities in which reflux increased after
valvuloplasty (χ2 = 11.5; P < .01). In the control group,
there was no significant difference in clinical results
between extremities with stable reflux and extremities with
increasing reflux (improvement in 66% and 63% of
extremities, respectively; P > .01). This observation con-
firms that the presence of deep venous reflux makes a sig-
nificant contribution to the severity of primary CVI.
There was no significant difference in clinical results
between extremities with increasing SFV reflux in the con-
trol group and extremities with increase in reflux after
valvuloplasty (improvement in 63% and 50% of extremities,
respectively; P > .1). In contrast, when extremities with sta-
ble valvular function in the control group were compared
with extremities with corrected valvular function, the latter
demonstrated superior results (clinical improvement in
66% and 92% of extremities, respectively; P < .005).
Changes in clinical class of the extremity were time-
correlated with changes in valvular function. At the time
when reflux reappeared or increase in the RVI was first
noted, none of the extremities showed an increase in clin-
ical class, but clinical aggravation occurred during the next
2 years after registration of the changes in reflux.
CONCLUSION
Our investigation showed that in patients with CVI,
two types of clinical dynamics, stable and progressive, can
be identified. The progressive type is associated with the
presence of SFV reflux and increasing GSV reflux.
Superficial vein surgery neither corrects SFV reflux nor
Fig 2. In 10 extremities of study group, RVI shows increase in reflux during follow-up.
prevents it from progressing further. Correction of a sin-
gle SFV valve at the time of superficial venous surgery sig-
nificantly improves the long-term results of the latter. This
improvement is associated with the prevention of reflux
progression. We therefore conclude that surgical correc-
tion of the incompetent SFV valve changes the course of
primary CVI.
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